Skip to content
Events

Register today to discover the latest news on how Illumina and Nanostring help to deliver on the promise of spatial biology. In this webinar, you will learn how to combine the GeoMx® DSP to provides insights into the complexity and diversity of the immune context of the tumor microenvironment from fresh frozen and FFPE tissue slides with high plex RNA assays with spatial information coupled with Illumina’s NextSeq 2000 platform.

Joseph Beechem, Ph.D.
Chief Scientific Officer & Sr. VP of Research & Development 
NanoString Technologies

 

Gary Schroth, Ph.D.
Vice President and Distinguished Scientist 
Illumina Sequencing

Details

Fill Out Form to Access Webinar
Date & Time
Jul 7, 2020
10:00 AM in Pacific Time (US and Canada)
Presenter
Joseph Beecham (Nanostring) and Gary Schroth (Illumina)
Topic
Cancer research, Cellular & molecular biology
Watch Now
For Research Use Only

Not for use in diagnostic procedures (except as specifically noted).

Innovative technologies

At Illumina, our goal is to apply innovative technologies to the analysis of genetic variation and function, making studies possible that were not even imaginable just a few years ago. It is mission critical for us to deliver innovative, flexible, and scalable solutions to meet the needs of our customers. As a global company that places high value on collaborative interactions, rapid delivery of solutions, and providing the highest level of quality, we strive to meet this challenge. Illumina innovative sequencing and array technologies are fueling groundbreaking advancements in life science research, translational and consumer genomics, and molecular diagnostics.

All trademarks are the property of Illumina, Inc. or their respective owners.
For specific trademark information, see www1.tst-web.illumina.com/company/legal.html.

© 2025 Illumina, Inc. All rights reserved.